Showing results (931-940 of 981) with videos related to
Sort By:
Pageof 99
Terapevticheskii Arkhiv|October 16, 2014
[Russian experts' clinical guidelines for acute myeloid leukemia treatment in patients less than 60 years of age]V G Savchenko, E N Parovichnikova, B V Afanas'ev, et al.Plos Genetics|May 20, 2016
The Splicing Efficiency of Activating HRAS Mutations Can Determine Costello Syndrome Phenotype and Frequency in CancerAnne-Mette Hartung, Jeff Swensen, Inaki E Uriz, et al.Meditsinskaia Tekhnika|March 1, 1996
[Organizational problems of the production of biological preparations of blood]A K Barsukov, V A Obukhov, O Iu Nesterova, et al.Acta Haematologica|April 24, 2020
A Prospective Pilot Study of Graft-versus-Host Disease Prophylaxis with Post-Transplantation Cyclophosphamide and Ruxolitinib in Patients with MyelofibrosisElena Vladislavovna Morozova, Maria Vladimirovna Barabanshikova, Ivan Sergeevich Moiseev, et al.Bone Marrow Transplantation|September 22, 2019
High prevalence of CD3, NK, and NKT cells in the graft predicts adverse outcome after matched-related and unrelated transplantations with post transplantation cyclophosphamideIvan S Moiseev, Elena V Babenko, Olga S Epifanovskaya, et al.Journal of Virology|May 15, 2015
Historical Outbreaks of Simian Hemorrhagic Fever in Captive Macaques Were Caused by Distinct ArterivirusesMichael Lauck, Sergey V Alkhovsky, Yīmíng Bào, et al.Journal of Neuro-Oncology|April 29, 2022
Cognitive function after concurrent temozolomide-based chemoradiation therapy in low-grade gliomasDeborah Y Park, Martin C Tom, Yanwen Chen, et al.Annals of Neurology|June 10, 2014
Immunoglobulin M oligoclonal bands: biomarker of targetable inflammation in primary progressive multiple sclerosisLuisa M Villar, Bonaventura Casanova, Nadia Ouamara, et al.Surgery|December 3, 2014
Comparison of tumor markers for predicting outcomes after resection of nonfunctioning pancreatic neuroendocrine tumorsJovenel Cherenfant, Mark S Talamonti, Curtis R Hall, et al.Journal of Neuro-Oncology|January 22, 2022
Quality of life following concurrent temozolomide-based chemoradiation therapy or observation in low-grade gliomaDeborah Y Park, Martin C Tom, Wei Wei, et al.Pageof 99